| Recruiting | Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB NCT06535568 | Fondazione Ricerca e Innovazione Cardiovascolare ETS | N/A |
| Recruiting | A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects NCT07319364 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 1 |
| Recruiting | Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-adv NCT06755684 | Peng Zhang | Phase 2 |
| Recruiting | Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma NCT06676527 | Jinling Hospital, China | — |
| Completed | A Study to Compare PK, Immunogenicity and Safety of Trastuzumab of Incepta Pharmaceuticals Ltd With Trastuzuma NCT06886659 | Incepta Pharmaceuticals Ltd | Phase 1 |
| Recruiting | Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma NCT05964101 | The First Affiliated Hospital of Guangzhou Medical University | Phase 2 |
| Unknown | Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery NCT04962958 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 2 |
| Active Not Recruiting | A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts NCT05288166 | Eli Lilly and Company | Phase 3 |
| Terminated | (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations NCT05241873 | Blueprint Medicines Corporation | Phase 1 |
| Terminated | (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC NCT05153408 | Blueprint Medicines Corporation | Phase 1 |
| Recruiting | Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors a NCT04572451 | Yana Najjar | Phase 1 |
| Unknown | Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma NCT05030077 | Tianjin Medical University Second Hospital | Phase 2 |
| Active Not Recruiting | Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cance NCT04807166 | Wenjun Cheng | Phase 2 |
| Terminated | (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC NCT04862780 | Blueprint Medicines Corporation | Phase 1 |
| Unknown | Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01) NCT04922047 | RenJi Hospital | Phase 1 / Phase 2 |
| Unknown | Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian NCT04556071 | Xiaoxiang Chen | Phase 2 |
| Unknown | Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer NCT04566952 | Xiaoxiang Chen | Phase 2 |
| Completed | TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC NCT04518852 | Sichuan Cancer Hospital and Research Institute | Phase 2 |
| Unknown | Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma NCT04309084 | Celularity Incorporated | Phase 1 |
| Recruiting | Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial) NCT03711110 | Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León | N/A |
| Completed | Anlotinib in Metastatic HER2 Negative Breast Cancer NCT04002284 | Peng Yuan | Phase 2 |
| Unknown | Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulatin NCT05814224 | Centro di Riferimento Oncologico - Aviano | N/A |
| Completed | Avelumab in Refractory Testicular Germ Cell Cancer. NCT03403777 | National Cancer Institute, Slovakia | Phase 2 |
| Unknown | Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study NCT03284255 | Shanghai Bio-heart Biological Technology Co., Ltd. | N/A |
| Unknown | Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and NCT03606369 | Instituto Nacional de Cancerologia de Mexico | Phase 2 / Phase 3 |
| Completed | Erbitux MEtastatic Colorectal Cancer Strategy Study NCT02484833 | Armando Orlandi | Phase 3 |
| Unknown | Does a Nursing Intervention Improve Adherence to Oral Chemotherapies in the Outpatient Cancer Treatment Settin NCT02468245 | Bassett Healthcare | N/A |
| Completed | Tablet-based Patient Reported Outcome NCT01991691 | University Hospital, Bonn | N/A |
| Completed | Acoustic Cardiographic Assessment of Heart Function in Comparison to Doppler-echocardiography NCT00541801 | Luzerner Kantonsspital | N/A |
| Completed | Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy NCT01316458 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients NCT01169792 | Yonsei University | — |